Join us on June 8 at 3 p.m. (EDT) to gain additional insight into appetite management in sick and healthy cats.
Cats are notoriously fussy about their food. So, it is easy to imagine the additional struggle sick cats in hospitals and cats with chronic health conditions must face with their intake and appetite. During this webcast, Dr. Jinelle Webb, internal medicine specialist, and Dr. Kelly St. Denis, feline specialist, will explore the challenges of encouraging appetite and maintaining intake for both the hospitalized patient and the cat with chronic health issues.
Join us on May 31st from noon to 1:30 p.m. (EDT) to see the positive effect change can bring to your practice.
Part 1 - Dr. Conny Mosley (20 min)
Is it time to change your approach to osteoarthritis?
Part 2 - Dr. Dave Nicol (60 min)
Step up or step back: Leading teams through change.
In this two-part webcast, Drs. Conny Mosley and Dave Nicol will discuss change from different perspectives: Dr. Mosley will discuss changing the approach to osteoarthritis (OA) treatment, while Dr. Nicol will analyze change from a team performance standpoint. Both will show that change is always a positive thing.
Join us on May 25th from 3 to 4:30 p.m. (EDT) to learn how to better assess and manage OA in your feline patients.
Feline osteoarthritis is underdiagnosed and the cause of chronic pain for many of our feline patients. In this webcast, Dr. Elizabeth O’Brien will look into how assessing cats for arthritis and diagnosing the disease is much easier than one would think, and treatment options are numerous and successful. So let’s all work together to make a difference in the lives of our feline patients by learning how to better diagnose and treat OA because “cats aren’t just old, they are sore”.
Following our feline specialists’ CE-accredited presentations, we invite you to stay on for an extra 30 minutes to learn about Solensia®.
Solensia® – Getting cats back to where they belong
Introducing Solensia®, the first monoclonal antibody therapy targeting nerve growth factor (NFG) to alleviate the pain of osteoarthritis (OA) in cats. NGF is one of the key mediators of OA pain and a new target for OA treatment. This session will provide an introduction to this exciting new monoclonal antibody therapy, discussing the mode of action, efficacy, safety, and clinical use. We will also share the positive experience from the other countries where the product has been available for almost a year.